Connect with us

Fertility

Infertility: how celebrities are changing the conversation

By Professor Alison Campbell, chief scientific officer at Care Fertility

Published

on

Celebrities can break down stigmas and build a sense of community around infertility and treatment but education and being realistic about an individual’s options is key, says Professor Alison Campbell, chief scientific officer at Care Fertility.

Infertility can be a lonely and isolating experience and may be incredibly difficult to discuss – especially with those unable to fully grasp what an individual or couple may be going through.

Fertility can be impacted by a number of factors such as age, lifestyle and medical factors. The main causes of fertility issues include ovulation problems, endometriosis, egg quality, sperm quality, PCOS, fallopian tube problems and premature ovarian insufficiency

For around a third of people, their infertility is considered unexplained; as there is no clear diagnosis.

However, there has been a significant shift in the conversation in recent years, partly driven by a growing number of celebrities who have spoken out about their own experiences.

From Chrissy Teigen’s openness about her infertility and miscarriages on her social channels to Khloe and Kourtney Kardashian’s very public journeys trying to conceive with IVF, celebrities have been much more transparent about their fertility journeys.

Such openness about issues and treatments has undoubtedly played a crucial role in raising awareness and normalising IVF treatments, along with shedding light on the challenges faced by millions of individuals and couples worldwide.

There are undeniable positives to be acknowledged when celebrities share their fertility journeys with the world.

Witnessing well-known figures discuss their journeys, struggles and successes, can encourage people to seek expert help and to feel less alone by fostering a sense of community, inclusivity and understanding.

It can also raise awareness of situations that might not be in the public eye, as with Courtney Cox discovering a rare condition preventing full-term pregnancy or Hugh Jackman’s openness about adoption and IVF.

When celebrities openly discuss their use of donors or surrogates, they contribute to an important conversation about solutions to infertility and the complexities of parenthood.

By sharing their stories, these celebrities help articulate and demonstrate how infertility and family-building can be diverse and multifaceted. This, in turn, may contribute to us becoming a more inclusive society that better understands the pain of infertility and accepts and promotes various paths to parenthood.

 

Kourtney Kardashian announcing her pregnancy in June 

The power of celebrity pregnancy reveals

When celebrities announce their pregnancies or the birth of their children, the media attention they receive often leads to an influx of public interest in fertility issues and treatments.

Searches for ‘Kourtney Kardashian IVF’ spiked (+700 per cent increase on 2022) * following her announcement, although it’s not known how the eldest Kardashian sister became pregnant.

Cameron Diaz and Priyanka Chopra have talked openly about using a surrogate which reportedly drove an increased interest in surrogacy.

 

View this post on Instagram

 

A post shared by Priyanka (@priyankachopra)

Priyanka Chopra used a surrogate to welcome her daughter, Malti

When Jennifer Aniston went public about her struggles to have a baby and said, “I would’ve given anything if someone had said to me, ‘Freeze your eggs. Do yourself a favour”, we saw a significant increase in interest in egg freezing and people also started asking more questions about fertility assessments.

This increased awareness can drive individuals to seek information and support, potentially encouraging those experiencing fertility challenges to explore fertility clinics, consult with specialists and consider IVF treatments.

Increased public awareness can bring issues front of mind at many levels. It may even prompt governments and healthcare institutions to allocate more resources and support for research towards infertility solutions.

Problematic aspects of celebrity pregnancy reveals

Whilst celebrity openness and pregnancy reveals have many positive aspects, there are also pitfalls to consider. It’s important to acknowledge that not every individual or couple can afford the same level of fertility investigations or treatments as celebrities.

When celebrities choose to share these issues, with sometimes millions of engaged followers, context and education is key.

The sometimes-high cost of repeated IVF treatments can create a sense of inequality, leaving many without access to the same options as those in the public eye. As fertility experts, we must strive to advocate for increased accessibility to fertility treatments and support for those facing financial barriers.

Not all celebrities will be as open with the more gritty or emotional details of their journeys. This can create a false sense of what appear to be seamless treatments, and successful pregnancies, which can inadvertently add pressure and stress to those struggling to conceive or undergoing fertility assessments or treatments.

Everyone’s fertility journey is unique, and not all cases end in immediate success. It is so important to remind the public that fertility treatments can be a challenging and emotionally taxing process, and that experiences and outcomes vary from person to person.

Celebrity influences can sometimes perpetuate unrealistic expectations about fertility treatments, leading some to believe that IVF guarantees a positive outcome or that it should be the first and only option.

As fertility experts, we must emphasise the importance of personalised treatment plans and individualised care for each patient, rather than a one-size-fits-all approach.

While celebrity revelations can raise awareness and positively influence public perception, we must remain balanced and address the challenging aspects, as well as the wonder of success, that constitute both sides of infertility.

Our responsibility lies in supporting those undergoing fertility investigations and treatments, advocating for increased accessibility and affordability, and promoting accurate, transparent information about the complexities of fertility journeys.

By combining the power of celebrity influence with ethical and compassionate care, we can work towards becoming a society that truly understands and supports those facing fertility challenges.

Professor Alison Campbell is chief scientific officer at Care Fertility.

Insight

IVFmicro raises £3.5m to boost IVF success

Published

on

IVFmicro has raised £3.5m to advance its microfluidic device designed to improve IVF success rates in routine clinic use.

The Leeds-based spinout from the University of Leeds, founded in 2024, aims to increase the quality and number of embryos in an IVF cycle.

IVF, or in vitro fertilisation, combines eggs and sperm in a lab before transferring embryos to the womb. A microfluidic device is a chip with tiny channels that move very small volumes of fluid.

The company says its device could raise the number of viable embryos available for transfer and the likelihood that an embryo will implant.

Currently, IVF leads to a successful pregnancy in about 30 per cent of cases for women under 35. A single cycle typically costs around £5,000 in the UK.

“My career has focused on understanding the reproductive biology of eggs and embryos, how they develop and, crucially, why things sometimes go wrong,” said IVFmicro co-founder and scientific director Helen Picton.

“At IVFmicro, we are harnessing years of research into reproductive biology to create a practical, accessible solution that can improve outcomes for patients undergoing fertility treatment. Our goal is to make IVF more effective, more predictable, and ultimately more hopeful for those striving to start a family.”

The investment was led by Northern Gritstone, with support from Innovate UK’s Investment Partnership Programme.

“IVFMicro is a brilliant example of the world-class innovation emerging from the Northern Arc’s universities, combining scientific excellence with a clear commercial vision to tackle the societal challenge of infertility,” said Northern Gritstone chief executive Duncan Johnson.

“Millions worldwide require fertility treatment, but new solutions are needed to overcome the high costs involved and low success rates. We are especially proud that IVFMicro’s journey has been supported through our NG Studios programme and our Innovation Services, which exist to help founders like Virginia and Helen turn pioneering research into real-world impact.”

Continue Reading

Features

University of Leeds IVF spinout raises £3.5m

Published

on

University of Leeds IVF spinout IVFmicro has raised £3.5m in pre-seed funding.

The investment is led by Northern Gritstone, with support from Innovate UK Investor Partnerships Programme, and will be used by IVFmicro for its next verification and validation phase, leading to trials on human embryos in fertility clinics.

Helen Picton is scientific director and co-founder of IVFmicro.

She said: “My career has focused on understanding the reproductive biology of eggs and embryos, how they develop and, crucially, why things sometimes go wrong.

“At IVFmicro, we are harnessing years of research into reproductive biology to create a practical, accessible solution that can improve outcomes for patients undergoing fertility treatment.

“Our goal is to make IVF more effective, more predictable, and ultimately more hopeful for those striving to start a family.”

Globally, 1 in 6 couples will face fertility issues, yet IVF success rates are suboptimal, with only 25-30 per cent succeeding in women under 35 years of age.

This is due in part to limitations of the embryo culture process, which typically involves repetitive handling, subjective selection of the best embryo, and the expense of highly skilled operators.

IVF is an expensive process, costing on average £5,000 for a patient in the UK for one cycle, accompanied by long NHS waiting lists that have selective criteria.

IVFmicro provides the first microfluidic device (a device for safely managing embryo culture and handling with very small amounts of nutrient-rich fluid) that can be used in any IVF treatment cycle.

This precision-engineered solution improves both the number of viable embryos available for transfer and the likelihood that an embryo will implant and result in a pregnancy.

IVFmicro provides a 10-15 per cent improvement in embryo quality and quantity, a significant leap that increases the potential to fall pregnant.

IVFmicro was founded in 2018 by Virginia Pensabene, Ph.D, and Helen Picton, Bsc, Ph.D., both professors at the University of Leeds.

Pensabene has published scientific advancements in microfluidics and brings her technical and scientific expertise to the product design.

Picton is a non-clinical expert in female reproductive biology and embryology, and has generated over £8m in research grant income.

IVFmicro recently took part in the NG Studios life sciences programme, which supports pre-seed life science businesses, and is delivered by accelerator KQ Labs, the Francis Crick Institute, and Northern Gritstone.

Virginia Pensabene, CEO and co-founder, IVFmicro, said: “As a biomedical engineer, I began exploring the potential of this technology in 2017, when Helen and I first met at the University of Leeds.

“From the start, our goal was to translate our research into a real solution for patients.

“Thanks to the combination of grant funding and Northern Gritstone’s support — both through investment and its innovation programmes — we have been able to grow our team in Leeds and take a major step toward bringing this precision-engineered IVF solution to market.”

Continue Reading

Mental health

Meta removes dozens of abortion advice and queer advocacy accounts

Published

on

Meta has removed or restricted dozens of accounts run by abortion providers, queer groups and reproductive health organisations in recent weeks.

Campaigners have called the takedowns one of the biggest waves of censorship on Meta’s platforms in years.

The actions began in October and targeted the Facebook, Instagram and WhatsApp accounts of more than 50 organisations worldwide, some serving tens of thousands of people.

Many were from Europe and the UK, with bans also affecting groups serving women in Asia, Latin America and the Middle East.

Repro Uncensored, an NGO tracking digital censorship against movements focused on gender, health and justice, said it had recorded 210 incidents of account removals and severe restrictions affecting these groups this year, compared with 81 last year.

Martha Dimitratou, executive director of Repro Uncensored, said: “Within this last year, especially since the new US presidency, we have seen a definite increase in accounts being taken down, not only in the US, but also worldwide as a ripple effect.

“This has been, to my knowledge, at least one of the biggest waves of censorship we are seeing.”

Meta denied any escalating trend of censorship and said its policies on abortion-related content had not changed.

“Every organisation and individual on our platforms is subject to the same set of rules, and any claims of enforcement based on group affiliation or advocacy are baseless,” it said in a statement.

Organisations affected include Netherlands-registered Women Help Women, a non-profit offering information about abortion to women worldwide that fields about 150,000 emails a year.

Kinga Jelinska, executive director of Women Help Women, said the ban could be “life-threatening”, pushing some women towards dangerous, less reliable information sources.

“It’s a very laconic explanation, a feeling of opacity,” Jelinska said. “They just removed it. That’s it. We don’t even know which post it was about.”

Meta said more than half of the accounts flagged by Repro Uncensored have been reinstated, including Women Help Women, which it said was taken down in error.

Continue Reading

Trending

Copyright © 2025 Aspect Health Media Ltd. All Rights Reserved.